Form 4: Illumina Director Scott B. Ullem Acquires Shares in Lieu of Cash Retainer

Director Scott B. Ullem acquired 229 shares of Illumina stock on March 31, 2025, in lieu of cash retainer fees.

Summary

• On March 31, 2025, Scott B. Ullem, a director of Illumina, Inc., acquired 229 shares of common stock.
• The acquisition was made in lieu of cash retainer fees for board and committee service.
• The price per share was $104.9218.
• Following the transaction, Mr. Ullem directly owns 5,120 shares of Illumina common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction indicating director alignment with shareholder interests, but doesn't contain any groundbreaking news.

Positives

• The director's decision to take shares in lieu of cash demonstrates confidence in the company's future.

Industry Context

Directors receiving stock in lieu of cash compensation is a common practice, aligning their interests with shareholders and conserving company cash.

Comparison to Industry Standards

• Stock-based compensation for board members is a common practice across the biotechnology industry.
• Companies like Thermo Fisher Scientific and Danaher also utilize stock awards as part of their director compensation packages.
• The specific amount and structure of these awards vary based on company size, performance, and compensation philosophy.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with shareholder value.

Key Dates

Keywords

Illumina, Director, Stock Acquisition, Form 4, Insider Trading, Ullem, Retainer Fees